Patent Policy and Innovation
This panel focused on how patent law affects various industries differently. The pharmaceutical and high-tech industries offer perhaps the most vivid examples of this divergence. Panelists discussed whether patent law currently is or should be technology specific, and also explored questions concerning which institutional actor would be in the best position to craft substantive patent law to promote innovation policy. Participants included the Honorable Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit, Dan Burk of the University of California Irvine School of Law, and Michael Meurer of the Boston University School of Law. The event was moderated by Melissa Wasserman, Academic Fellow at the Petrie-Flom Center.
Tags
biotechnology intellectual property judicial opinions pharmaceuticals regulation